Home Taysha Gene Therapies

Taysha Gene Therapies

In operation
Post-IPO Round
Gene Therapy Drug Developer
Basic
Enterprise Profile

Basic Information

Taysha Gene Therapies (hereinafter referred to as "Taysha Gene") is headquartered in Dallas, Texas, USA. It is a gene therapy company specializing in monogenic genetic disorders of the central nervous system. Taysha Gene has partnered with The University of Texas Southwestern Medical Center (referred to as "UT Southwestern"), the most renowned medical center in the southwestern United States, aiming for rapid clinical translation. They have developed various gene therapy drugs using adenoviruses as vectors.
Taysha Gene Therapies, Inc.
Dallas,Texas,United States of America
15~50 people
January 01, 2020
info@tayshagtx.com

Enterprise Profile

Industrial Sector
New Drug Development Gene Therapy Biological Drug Production
Technology
Biotechnology Genetic Engineering
Concept
Rare Diseases Therapeutic Products
Application Scenarios
Innovative Drugs Cell and Gene Therapy